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Volume 72, Number 1For patients with abdominal aortic aneurysms >5.5 cm,
it will be a time of apprehension and frustration.
Having been on surveillance for years and reached the
threshold for intervention, suddenly they are being told
that risk-benefit ratio does not favor surgery in those
with <7-cm abdominal aortic aneurysms (6.5 cm in the
American College of Surgeons recommendations). It
will be interesting to see how many of them leak or
rupture and need an emergency endovascular or open
repair.
The effect on surgical training, too, will be immense as
surgical residents are redeployed in critical care. The
training has essentially been paused and, once it is all
over, will have to be extended.
As we sit back and wait for the COVID-19 blanket to lift,
the surgical world could be a very different place. Let us
not let COVID-19 become a death note for surgery but
maintain data and accurately document outcomes to
recalibrate what we do.
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the era of the COVID-19 pandemicIn Portugal, a state of emergency was declared on
March 18 because of the COVID-19 pandemic. Every
nonessential business and activity was ceased, and
home confinement was required for everyone not
involved in essential activities.
This pandemic has brought significant changes to our
personal and professional lives. Patients with vascular
diseases are especially prone to development of
complicated disease if infected by SARS-CoV-2.1 It is
our responsibility as vascular surgeons to protect our
patients while keeping an active practice because most
of our patients have a life- or limb-threatening disease.
We work in a tertiary university hospital in Lisbon, the
capital of Portugal,whichhas auniversal public health sys-
tem. Our department is one of largest in the country and
accommodates a significant part of all referrals to vascular
surgery, including complex aortic diseases, with an annual
volume of approximately 1700 vascular procedures. Most
of our patients treated are urgent or emergent.
Among many other issues, this pandemic presented us
with a considerable dilemma. As our hospital is the largest
in Lisbon, we had to accommodate a significant number
of the COVID-19 patients, including a high demand for
intensive care unit (ICU) beds. Under these circumstances,
how could we protect our patients and simultaneously
keep up a practice to respond to urgent cases?
First, we postponed and discharged every patient
we considered nonurgent: asymptomatic carotid
stenosis, non-limb-threatening ischemia, aortic
aneurysm <5.5 cm, and vascular malformations. All
outpatient clinics were carried out by telemedicine,
and only urgent patients were seen in person.
Second, we divided our entire staff into two teams alter-
nating on a week-to-week basis. The staff with some ICU
experience started to have specific ICU training to be
called on to support COVID-19 ICUs if the hospital needed
it. Senior staff was put on leave to be called on if necessary.
All of this was done to obtain amaximum reserve of team
members. Staff symptom checking was routinely per-
formed to ensure that no one had contracted the disease,
and all positive nonprotected contacts were sent home
for quarantine.
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limb-threatening ischemia, symptomatic carotid
stenosis, and aortic aneurysm >5.5 cm) and emergent
patients. Whenever possible, we opted for an approach
that shortened the length of stay: endovascular
aneurysm repair, percutaneous approach, and use of
local or regional anesthesia.
In the hospital, wards were divided into three
types: triage (waiting for a SARS-CoV-2 result) and
COVID-19 or non-COVID-19 wards. The same was done
for ICUs.
As a measure to increase the ICU capacity, the
vascular surgery ward was turned into an ICU to
COVID-19 patients, which led us to reformulate the
entire Heart and Vessels Department. In general, the
noninfected vascular surgery patients are admitted in
cardiothoracic surgery wards and infected patients in
the cardiology wards.
The operating rooms were also divided into SARS-
CoV-2-positive rooms, where full protection equip-
ment is used, and SARS-CoV-2-negative rooms.
Patients had to be asymptomatic and to have a
negative test result to be operated on in the SARS-
CoV-2-negative operating room. Emergent cases
were assumed to be positive, and the recovery period
took place in a triage ward or ICU until a test result
was present.
So far, we have seen a significant decrease in the
number of vascular urgent cases and even emergencies,
which is probably due to the population confinement
measures (reducing trauma, for example) and to patients
being afraid to go to the hospital. There is a huge
concern that after the crisis, we may end up with
advanced stages of vascular diseases, like higher degrees
of unsalvageable limbs.
So far, we have been able to maintain an active practice
and to treat all urgent and emergent cases and have had
no infections among our staff.
Some questions are now emerging regarding the true
future impact of the pandemic state:
1. What will be the outcome of vascular patients who
develop COVID-19?
2. What is the real impact on the outcome of elective
patients who are being systematically postponed
because of the current pandemic, and how will
we be able to treat them in the future and at
what cost?
3. Can the public health system accommodate the
impact cost, and will we be able to deliver the
same clinical standard of care to the huge number
of patients who have seen their treatment post-
poned or canceled?
4. How will the weaning period be processed? What
will be the right time to dismantle the ICUs andrecover the vascular surgery ward to return to
normal activity (can a short relapse of the pandemic
state be predicted)?
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change due to COVID-19 at a nonacademic
tertiary care centerThe 2019-novel coronavirus (COVID-19) has over-
whelmed healthcare systems across the world, and has
also affected specialized practices such as vascular
surgery. The first case in the United States was diagnosed
on January 19, 2020. This prompted many healthcare
systems, including our institution, to initiate preemptive
measures in preparation for the anticipated surge of
patients. The first case in Minnesota was diagnosed on
March 4, first death on March 21, and the projected daily
death peak is April 26.1,2 Recommendations on social
distancing from the Centers for Disease Control and
Prevention as well as the subsequent state-wide stay at
home order in Minnesota, are aimed at slowing viral
spread and providing more time for hospital preparation
for the surge.3,4
In light of these recommendations, we instituted
drastic changes to our clinical practice on March 23 in
accordance with the American College of Surgeons
COVID recommendations for elective procedures.5 This
process involved postponing all elective procedures,
with the exception of those deemed necessary for
immediately life- or limb-threatening conditions. Each
case that has subsequently been performed has required
independent review and approval by leadership from our
section. To ensure postponed procedures are not
